| Literature DB >> 26407191 |
Pascal Caillet1, Cécile Payet2, Stéphanie Polazzi2, Matthew J Carty3, Jean-Christophe Lifante4, Antoine Duclos5.
Abstract
Surgical safety during vacation periods may be influenced by the interplay of several factors, including workers' leave, hospital activity, climate, and the variety of patient cases. This study aimed to highlight an annually recurring peak of surgical mortality during summer in France and explore its main predictors. We selected all elective of open surgical procedures performed in French hospitals between 2007 and 2012. Surgical mortality variation was analyzed over time in relation to workers leaving on vacation, the volume of procedures performed by hospitals, and temperature changes. We ran a multilevel logistic regression for exploring the determinants of surgical mortality, taking into account the clustering of patients within hospitals and adjusting for patient and hospital characteristics. A total of 609 French hospitals had 8,926,120 discharges related to open elective surgery. During 6 years, we found a recurring mortality peak of 1.15% (95% CI 1.09-1.20) in August compared with 0.81% (0.79-0.82, p<.001) in other months. The incidence of worker vacation was 43.0% (38.9-47.2) in August compared with 7.3% (4.6-10.1, p<.001) in other months. Hospital activity decreased substantially in August (78,126 inpatient stays, 75,298-80,954) in relation to other months (128,142, 125,697-130,586, p<.001). After adjusting for all covariates, we found an "August effect" reflecting a higher risk to patients undergoing operations at this time (OR 1.16, 95% CI 1.12-1.19, p<.001). The main study limitation was the absence of data linkage between surgical staffing and mortality at the hospital level. The observed, recurring mortality peak in August raises questions about how to maintain hospital activity and optimal staffing through better regulation of human activities.Entities:
Mesh:
Year: 2015 PMID: 26407191 PMCID: PMC4583258 DOI: 10.1371/journal.pone.0137754
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Study flowchart.
Flow diagram of hospitals and stays selected for inclusion.
Hospitals and populations studied in France.
|
|
|
|
| Monthly volume of stays per hospital, mean (SD) | 237.0 (349.7) | - |
| Monthly temperature per hospital, mean (SD) | 16.9 (1.8) | - |
| Status | ||
|
| 48 | 7.9 |
|
| 260 | 42.7 |
|
| 301 | 49.4 |
| Geographic location | ||
|
| 121 | 19.9 |
|
| 102 | 16.7 |
|
| 160 | 26.3 |
|
| 85 | 14.0 |
|
| 141 | 23.2 |
|
|
|
|
| Inpatient mortality | 73,477 | 0.8 |
| Year | ||
|
| 1,545,068 | 17.3 |
|
| 1,535,327 | 17.2 |
|
| 1,493,460 | 16.7 |
|
| 1,459,603 | 16.4 |
|
| 1,452,632 | 16.3 |
|
| 1,440,030 | 16.1 |
| Women | 4,648,989 | 52.1 |
| Age (years), mean (SD) | 58.2 (17.7) | - |
| No. different Elixhauser comorbidities, | 0.8 (1.1) | - |
| Surgical procedure codes | ||
|
| 267,287 | 3.0 |
|
| 481,417 | 5.4 |
|
| 1,396,807 | 15.6 |
|
| 321,201 | 3.6 |
|
| 132,926 | 1.5 |
|
| 859,637 | 9.6 |
|
| 209,809 | 2.4 |
|
| 986,981 | 11.1 |
|
| 274,791 | 3.1 |
|
| 3,494,955 | 39.2 |
|
| 1,326,220 | 14.9 |
| Procedure complexity, mean (SD) | 364.8 (291.4) | - |
| Month | ||
|
| 783,138 | 8.8 |
|
| 798,006 | 8.9 |
|
| 848,363 | 9.5 |
|
| 771,396 | 8.6 |
|
| 732,360 | 8.2 |
|
| 765,809 | 8.6 |
|
| 664,904 | 7.4 |
|
| 468,758 | 5.3 |
|
| 737,604 | 8.3 |
|
| 860,629 | 9.6 |
|
| 762,169 | 8.5 |
|
| 732,984 | 8.2 |
a Elixhauser comorbidities include congestive heart failure, cardiac arrhythmias, valvular disease, pulmonary circulation disorders, peripheral vascular disorders, hypertension uncomplicated/complicated, paralysis, other neurological disorders, chronic pulmonary disease, diabetes uncomplicated/complicated, hypothyroidism, renal failure, liver disease, peptic ulcer disease excluding bleeding, AIDS/HIV, lymphoma, metastatic cancer, solid tumour without metastasis, rheumatoid arthritis/collagen vascular diseases, coagulopathy, obesity, weight loss, fluid and electrolyte disorders, blood loss anaemia, deficiency anaemia, alcohol abuse, drug abuse, psychoses, and depression.
Fig 2Seasonal pattern of surgical mortality.
These figures present the monthly change in crude mortality rate by year (2a), surgical specialty (2b) and quartile of hospital mortality (2c).
Fig 3Seasonal pattern of predictors.
The figures present the monthly changes in mortality rates (3a), along with those of workers' leave (3b), hospital activity (3c) and maximum temperatures (3d).
Population comparison between August and other months.
| Characteristics | Other Months Mean N = 768,851 (%) | August N = 468,758 (%) |
|---|---|---|
| Hospital geographic location | ||
|
| 119,292 (15.5) | 62,736 (13.4) |
|
| 158,161 (20.6) | 98,808 (21.1) |
|
| 170,139 (22.1) | 112,016 (23.9) |
|
| 122,022 (15.9) | 77,426 (16.5) |
|
| 199,238 (25.9) | 117,772 (25.1) |
| Hospital status | ||
|
| 193,743 (25.2) | 135,150 (28.8) |
|
| 188,714 (24.5) | 120,686 (25.7) |
|
| 386,394 (50.3) | 212,922 (45.4) |
| Year | ||
|
| 132,938 (17.3) | 82,754 (17.7) |
|
| 132,344 (17.2) | 79,542 (17.0) |
|
| 128,653 (16.7) | 78,279 (16.7) |
|
| 125,765 (16.4) | 76,188 (16.3) |
|
| 125,135 (16.3) | 76,143 (16.2) |
|
| 124,016 (16.1) | 75,852 (16.2) |
| Women | 401,291 (52.2) | 234,785 (50.1) |
| Age (years), mean (SD) | 58.2 (17.7) | 58.2 (18.6) |
| No. different Elixhauser comorbidities, | 0.8 (1.1) | 0.8 (1.2) |
| Surgical procedure codes | ||
|
| 22,885 (3.0) | 15,550 (3.3) |
|
| 41,667 (5.4) | 23,078 (4.9) |
|
| 120,218 (15.6) | 74,414 (15.9) |
|
| 27,260 (3.5) | 21,341 (4.6) |
|
| 11,232 (1.5) | 9,373 (2.0) |
|
| 73,106 (9.5) | 55,466 (11.8) |
|
| 18,047 (2.3) | 11,290 (2.4) |
|
| 85,180 (11.1) | 50,006 (10.7) |
|
| 23,910 (3.1) | 11,786 (2.5) |
|
| 302,326 (39.3) | 169,365 (36.1) |
|
| 113,465 (14.8) | 78,110 (16.7) |
| Procedure complexity, mean (SD) | 365.1 (290.8) | 359.8 (301.8) |
a p<.001 for all variables.
b Elixhauser comorbidities include congestive heart failure, cardiac arrhythmias, valvular disease, pulmonary circulation disorders, peripheral vascular disorders, hypertension uncomplicated/complicated, paralysis, other neurological disorders, chronic pulmonary disease, diabetes uncomplicated/complicated, hypothyroidism, renal failure, liver disease, peptic ulcer disease excluding bleeding, AIDS/HIV, lymphoma, metastatic cancer, solid tumour without metastasis, rheumatoid arthritis/collagen vascular diseases, coagulopathy, obesity, weight loss, fluid and electrolyte disorders, blood loss anaemia, deficiency anaemia, alcohol abuse, drug abuse, psychoses, and depression.
Factors independently associated in-hospital death within 30 days.
| Characteristics | OR (95% CI) |
|---|---|
| August (Ref = Other months) | 1.16 (1.12–1.19) |
|
| 1.15 (1.10–1.20) |
|
| 1.18 (1.12–1.24) |
|
| 1.36 (1.16–1.58) |
| Hospital geographic location (Ref = Paris) | |
|
| 0.89 (0.77–1.02) |
|
| 0.89 (0.78–1.01) |
|
| 0.88 (0.76–1.01) |
|
| 1.02 (0.90–1.16) |
| Hospital status (Ref = Private for profit) | |
|
| 1.67 (1.44–1.93) |
|
| 1.82 (1.68–1.97) |
| Year of hospital discharge (Ref = 2012) | |
|
| 1.46 (1.42–1.50) |
|
| 1.39 (1.35–1.43) |
|
| 1.24 (1.21–1.28) |
|
| 1.16 (1.13–1.19) |
|
| 1.09 (1.06–1.12) |
| Women (Ref = Men) | 0.80 (0.79–0.81) |
| Age (by 1 year increase) | 1.06 (1.05–1.06) |
| No. different Elixhauser comorbidities (by 1 comorbidity increase) | 1.59 (1.59–1.60) |
| Surgical procedure codes (Ref = Other site) | |
|
| 4.02 (3.87–4.18) |
|
| 0.82 (0.77–0.88) |
|
| 2.53 (2.47–2.60) |
|
| 0.80 (0.76–0.83) |
|
| 5.61 (5.41–5.82) |
|
| 5.33 (5.21–5.46) |
|
| 1.42 (1.35–1.49) |
|
| 0.45 (0.43–0.47) |
|
| 0.38 (0.33–0.43) |
|
| 1.05 (1.02–1.07) |
|
| 1.21 (1.17–1.25) |
| Procedure complexity (by 100 unit increase) | 1.04 (1.04–1.04) |
a p<.001 for all variables excepted hospital geographic location, based on multilevel logistic regression model.
b Elixhauser comorbidities include congestive heart failure, cardiac arrhythmias, valvular disease, pulmonary circulation disorders, peripheral vascular disorders, hypertension uncomplicated/complicated, paralysis, other neurological disorders, chronic pulmonary disease, diabetes uncomplicated/complicated, hypothyroidism, renal failure, liver disease, peptic ulcer disease excluding bleeding, AIDS/HIV, lymphoma, metastatic cancer, solid tumour without metastasis, rheumatoid arthritis/collagen vascular diseases, coagulopathy, obesity, weight loss, fluid and electrolyte disorders, blood loss anaemia, deficiency anaemia, alcohol abuse, drug abuse, psychoses, and depression.